Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for ...
Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...
By Ebenezer Chike Adjei NJOKU Dr. Davies Kofie Adedze, a leading advocate for regenerative medicine, has stated that stem cell therapy could significantly reduce the country’s burden of ...
Immunotherapy is key for triple-negative breast cancer, but a new study finds Black women are receiving it less often than White women.